Humacyte, Inc. Increase Decrease In Operating Lease Liability
Humacyte, Inc. (HUMA) reported Increase Decrease In Operating Lease Liability of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-12
- Humacyte, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was $0.00.
- Humacyte, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was $0.00.
- Humacyte, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was $0.00.
- Humacyte, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$15.00K.
- Humacyte, Inc. increase decrease in operating lease liability for fiscal 2025 was -$44.00K.
- Humacyte, Inc. increase decrease in operating lease liability for fiscal 2024 was -$53.00K.
- Humacyte, Inc. increase decrease in operating lease liability for fiscal 2023 was -$50.00K.
- Humacyte, Inc. increase decrease in operating lease liability for fiscal 2022 was -$45.00K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | $0.00 10-Q · filed 2026-08-12 | $0.00 derived: sum of 3 quarters · filed 2026-08-12 | -$15.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-13 | $0.00 derived: sum of 2 quarters · filed 2026-05-13 | -$15.00K derived: sum of 3 quarters · filed 2026-05-13 | -$30.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$15.00K derived: sum of 2 quarters · filed 2026-03-27 | -$30.00K derived: sum of 3 quarters · filed 2026-08-12 | -$44.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | -$15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$30.00K derived: sum of 2 quarters · filed 2026-08-12 | -$44.00K 10-Q · filed 2025-11-12 | -$58.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$29.00K 10-Q · filed 2026-08-12 | -$43.00K derived: sum of 3 quarters · filed 2026-08-12 | -$56.00K derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-03-31 | -$14.00K 10-Q · filed 2026-05-13 | -$28.00K derived: sum of 2 quarters · filed 2026-05-13 | -$41.00K derived: sum of 3 quarters · filed 2026-05-13 | -$54.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | -$14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | -$27.00K derived: sum of 2 quarters · filed 2026-03-27 | -$40.00K derived: sum of 3 quarters · filed 2026-03-27 | -$53.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$26.00K derived: sum of 2 quarters · filed 2025-11-12 | -$39.00K 10-Q · filed 2025-11-12 | -$52.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$26.00K 10-Q · filed 2025-08-11 | -$39.00K derived: sum of 3 quarters · filed 2025-08-11 | -$52.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | -$13.00K 10-Q · filed 2025-05-13 | -$26.00K derived: sum of 2 quarters · filed 2025-05-13 | -$39.00K derived: sum of 3 quarters · filed 2025-05-13 | -$51.00K derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$26.00K derived: sum of 2 quarters · filed 2025-03-31 | -$38.00K derived: sum of 3 quarters · filed 2025-03-31 | -$50.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$25.00K derived: sum of 2 quarters · filed 2024-11-08 | -$37.00K 10-Q · filed 2024-11-08 | -$48.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$24.00K 10-Q · filed 2024-08-13 | -$35.00K derived: sum of 3 quarters · filed 2024-08-13 | -$47.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$12.00K 10-Q · filed 2024-05-13 | -$23.00K derived: sum of 2 quarters · filed 2024-05-13 | -$35.00K derived: sum of 3 quarters · filed 2024-05-13 | -$46.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$23.00K derived: sum of 2 quarters · filed 2024-03-28 | -$34.00K derived: sum of 3 quarters · filed 2024-03-28 | -$45.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$23.00K derived: sum of 2 quarters · filed 2023-11-09 | -$34.00K 10-Q · filed 2023-11-09 | -$44.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$22.00K 10-Q · filed 2023-08-14 | -$32.00K derived: sum of 3 quarters · filed 2023-08-14 | -$43.00K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$11.00K 10-Q · filed 2023-05-12 | -$21.00K derived: sum of 2 quarters · filed 2023-05-12 | -$32.00K derived: sum of 3 quarters · filed 2023-05-12 | -$42.00K derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | -$21.00K derived: sum of 2 quarters · filed 2023-03-24 | -$31.00K derived: sum of 3 quarters · filed 2023-03-24 | -$42.00K 10-K · filed 2023-03-24 |
| 2021-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | -$21.00K derived: sum of 2 quarters · filed 2022-11-10 | -$32.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | -$10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | -$21.00K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | -$11.00K 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | -$82.00K 10-K · filed 2022-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |